参考文献/References:
[1] Khan KS,Wojdyla D,Say L,et al.WHO analysis of causes of maternal death:a systematic review[J].Lancet,2006,367(9516):1066-1074.
[2] 齐红燕,郭海燕,杨爱君.小剂量阿司匹林对子痫前期的预防作用及安全性研究[J].陕西医学杂志,2019,48(4):528-530.
[3] Wright D,Rolnik DL,Syngelaki A,et al.Aspirin for evidence-based preeclampsia prevention trial:effect of aspirin on length of stay in the neonatal intensive care unit[J].Am J Obstet Gynecol,2018,218(6):612-616.
[4] National Institute for Health and Care Excellence.Hypertension in pregnancy:The management of hypertensive disorders during pregnancy[M].London:RCOG Press,2010.
[5] Committee Opinion No.638.First-trimester risk assessment for early-onset preeclampsia[J].Obstet Gynecol,2015,126(3):25-27.
[6] O'Gorman N,Wright D,Poon LC,et al.Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation[J].Ultrasound Obstet Gynecol,2017,49(6):751-755.
[7] Wright D,Syngelaki A,Akolekar R,et al.Competing risks model in screening for preeclampsia by maternal characteristics and medical history[J].Am J Obstet Gynecol,2015,213(1):62-72.
[8] North RA,Mc Cowan LM,Dekker GA,et al.Clinical risk prediction for pre-eclampsia in nulliparous women:development of model in international prospective cohort[J].BMJ,2011,342:1875.
[9] Harris LK,Keogh RJ,Wareing M,et al.Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas ligand-dependent mechanism[J].Am J Pathol,2006,169(5):1863-1874.
[10] Cnossen JS,Vollebregt KC,De Vrieze N,et al.Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia:systematic review and meta-analysis[J].BMJ,2008,336(7653):1117-1120.
[11] Poon LC,Kametas NA,Pandeva I,et al.Mean arterial pressure at 11(+0)to 13(+6)weeks in the prediction of preeclampsia[J].Hypertension,2008,51(4):1027-1033.
[12] Spencer K,Cowans NJ,Chefetz I,et al.First-trimester maternal serum PP-13,PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia[J].Ultrasound Obstet Gynecol,2007,29(2):128-134.
[13] 段晓宇,许碧云,南子晴,等.早孕期不同预测模型预测早发型子痫前期效果的系统评价[J].中华围产医学杂志,2018,35(4):266-275.
[14] Poon LC,Akolekar R,Lachmann R,et al.Hypertensive disorders in pregnancy:screening by biophysical and biochemical markers at 11-13 weeks[J].Ultrasound Obstet Gynecol,2010,35(6):662-670.
[15] Cnossen JS,Morris RK,Terriet G,et al.Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction:a systematic review and bivariable meta-analysis[J].CMAJ,2008,178(6):701-711.
[16] Velauthar L,Plana MN,Kalidindi M,et al.First-trimester uterine artery doppler and adverse pregnancy outcome:a meta-analysis involving 55,974 women[J].Ultrasound Obstet Gynecol,2014,43(5):500-507.
[17] Wright D,Akolekar R,Syngelaki A,et al.A competing risks model in early screening for preeclampsia[J].Fetal Diagn Ther,2012,32(3):171-178.
[18] Poon LC,Nicolaides KH.Early prediction of preeclampsia[J].Obstet Gynecol Int,2014,2014:297397.
[19] Lu F,Longo M,Tamayo E,et al.The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice[J].Am J Obstet Gynecol,2007,196(4):396343.
[20] Frang H,Hurskainen P,Nicolaides K,et al.PIGF isoform 3 in maternal serum and placental tissue[J].Pregnancy Hypertens,2019,18:9-13.
[21] Tsiakkas A,Duvdevani N,Wright A,et al.Serum placental growth factor in the three trimesters of pregnancy:effects of maternal characteristics and medical history[J].Ultrasound Obstet Gynecol,2015,45(5):591-598.
[22] Chappell LC,Duckworth S,Seed PT,et al.Diagnostic accuracy of placental growth factor in women with suspected preeclampsia:a prospective multicenter study[J].Circulation,2013,128(19):2121-2131.
[23] 俞春芝,赵现立.子痫前期和正常妊娠患者血清及胎盘组织中sFlt-1的表达研究[J].陕西医学杂志,2014,43(10):1295-1295.
[24] Kleinrouweler CE,Wiegerinck MM,Ris-Stalpers C,et al.Accuracy of circulating placental growth factor,vascular endothelial growth factor,soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia:a systematic review and meta-analysis[J].BJOG,2012,119(7):778-787.
[25] Rana S,Powe CE,Salahuddin S,et al.Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia[J].Circulation,2012,125(7):911-919.
[26] Tardif C,Dumontet E,Caillon H,et al.Angiogenic factors sFlt-1 and PIGF in preeclampsia:prediction of risk and prognosis in a high-risk obstetric population[J].J Gynecol Obstet Hum Reprod,2018,47(1):17-21.
[27] Venkatesha S,Toporsian M,Lam C,et al.Soluble endoglin contributes to the pathogenesis of preeclampsia[J].Nat Med,2006,12(6):642-649.
[28] Levine RJ,Maynard SE,Qian C,et al.Circulating angiogenic factors and the risk of preeclampsia[J].N Engl J Med,2004,350(7):672-683.
[29] Sachan R,Patel ML,Dhiman S,et al.Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia[J].Adv Biomed Res,2016,5:119.
[30] Kleinrouweler CE,Wiegerinck MM,Ris-Stalpers C,et al.Accuracy of circulating placental growth factor,vascular endothelial growth factor,soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia:a systematic review and meta-analysis[J].BJOG,2012,119(7):778-787.
[31] Conde-Agudelo A,Bird S,Kennedy SH,et al.First-and second-trimester tests to predict stillbirth in unselected pregnant women:a systematic review and meta-analysis[J].BJOG,2015,122(1):41-55.
[32] Smith GC,Stenhouse EJ,Crossley JA,et al.Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction,premature birth,preeclampsia,and stillbirth[J].J Clin Endocrinol Metab,2002,87(4):1762-1767.
[33] 顾 玮,林 婧,侯燕燕.妊娠早中期孕妇血清中β-hCG、PAPP-A、AFP及uE3水平检测在联合预测子痫前期中的价值[J].中华妇产科杂志,2015,47(2):101-107.
[34] Xu YT,Shen MH,Jin AY,et al.Maternal circulating levels of transforming growth factor-beta superfamily and its soluble receptors in hypertensive disorders of pregnancy[J].Int J Gynaecol Obstet,2017,137(3):246-252.
[35] Ree PH,Hahn WB,Chang SW,et al.Early detection of preeclampsia using inhibin a and other second-trimester serum markers[J].Fetal Diagn Ther,2011,29(4):280-286.
[36] Sibai BM,Koch MA,Freire S,et al.Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension:are they useful markers for prediction of subsequent preeclampsia[J].Am J Obstet Gynecol,2008,199(3):268-277.
[37] Ree PH,Hahn WB,Chang SW,et al.Early detection of preeclampsia using inhibin a and other second-trimester serum markers[J].Fetal Diagn Ther,2011,29(4):280-286.
[38] Akolekar R,Syngelaki A,Sarquis R,et al.Prediction of early,intermediate and late pre-eclampsia from maternal factors,biophysical and biochemical markers at 11-13 weeks[J].Prenat Diagn,2011,31(1):66-74.
[39] Gonen R,Shahar R,Grimpel YI,et al.Placental protein 13 as an early marker for pre-eclampsia:a prospective longitudinal study[J].BJOG,2008,115(12):1465-1472.
[40] Poon LCY,Kametas NA,Chelemen T,et al.Maternal risk factors for hypertensive disorders in pregnancy:a multivariate approach[J].J Hum Hypertens,2010,24(2):104-110.
[41] Yu CK,Smith GC,Papageorghiou AT,et al.An integrated model for the prediction of preeclampsia using maternal factors and uterine artery doppler velocimetry in unselected low-risk women[J].Am J Obstet Gynecol,2005,193(2):429-436.
[42] Kenny LC,Black MA,Poston L,et al.Early pregnancy prediction of preeclampsia in nulliparous women,combining clinical risk and biomarkers:the Screening for Pregnancy Endpoints(SCOPE)international cohort study[J].Hypertension,2014,64(3):644-652.
[43] Oliveira N,Magder LS,Blitzer MG,et al.First-trimester prediction of pre-eclampsia:external validity of algorithms in a prospectively enrolled cohort[J].Ultrasound Obstet Gynecol,2014,44(3):279-285.
[44] O'Gorman N,Wright D,Syngelaki A,et al.Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation[J].Am J Obstet Gynecol,2016,214(1):103-115.
[45] Rolnik DL,Wright D,Poon L,et al.ASPRE trial:performance of screening for preterm pre-eclampsia[J].Ultrasound Obstet Gynecol,2017,50(4):492-495.
[46] Wright D,Tan MY,O'Gorman N,et al.Predictive performance of the competing risk model in screening for preeclampsia[J].Am J Obstet Gynecol,2019,220(2):199-132.
[47] Wright D,Gallo DM,Gil PS,et al.Contingent screening for preterm pre-eclampsia[J].Ultrasound Obstet Gynecol,2016,47(5):554-559.
相似文献/References:
[1]黄丽琼,郑 波△,张元珍,等.2甲氧雌二醇在早发型子痫前期患者中的表达及临床意义*[J].陕西医学杂志,2019,(2):208.
HUANG Liqiong,ZHENG Bo,ZHANG Yuanzhen,et al.The expression and clinical significances of 2methoxyestradiol in earlyonset preeclampsia[J].,2019,(8):208.
[2]齐红燕,郭海燕,杨爱君.小剂量阿司匹林对子痫前期的预防作用及安全性研究*[J].陕西医学杂志,2019,(4):528.
[3]黄敏华,孙雁智△.稳定性冠心病患者血清抵抗素水平与心肌梗死相关性研究[J].陕西医学杂志,2020,49(2):187.
HUANG Minhua,SUN Yanzhi..Correlation between serum resistin level and myocardial infarction in patients with stable coronary heart disease[J].,2020,49(8):187.
[4]王 琪,卢朝祥△,陈晓峰,等.预测6月龄以下骶尾部畸胎瘤良恶性的列线图建立研究[J].陕西医学杂志,2020,49(3):313.
WANG Qi,LU Chaoxiang,CHEN Xiaofeng,et al.Establishment of anomogram for predicting benign and malignant sacrococcygeal teratomas below 6 months[J].,2020,49(8):313.
[5]田 鹏,蔡盈盈,孙春丽,等.衰弱对社区老年人骨折预测作用的系统评价[J].陕西医学杂志,2020,49(3):370.
[6]张 丽,赵莉娜,彭 静,等.子痫前期孕妇血清白细胞介素17、和肽素及血小板内皮细胞黏附分子1水平检测及临床意义[J].陕西医学杂志,2020,49(11):1515.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.038]
ZHANG Li,ZHAO Lina,PENG Jing,et al.Detection and significance of serum IL-17,CPT and PECAM-1 in pregnant women with preeclampsia[J].,2020,49(8):1515.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.038]
[7]王新香,张朝红.血清性激素和胰岛素水平对子宫内膜异位症合并不孕症的预测价值[J].陕西医学杂志,2021,50(1):41.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.010]
[8]蒋晓颖,赵雪卉,张 娟.妊娠高血压早期肾损伤情况及其与血清视黄醇结合蛋白、尿酸关系研究[J].陕西医学杂志,2021,50(2):151.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.006]
JIANG Xiaoying,ZHAO Xuehui,ZHANG Juan.Early renal injury in gestational hypertension and its relationship with serum sRBP and UA[J].,2021,50(8):151.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.006]
[9]杨 帆,高 盼.血小板参数、D-二聚体在妊娠高血压综合征早期肾损伤患者中的表达及临床意义[J].陕西医学杂志,2021,50(4):413.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.007]
YANG Fan,GAO Pan.Expression and clinical significance of platelet parameters and D-dimer in patients with early-stage renal injury in pregnancy-induced hypertension syndrome[J].,2021,50(8):413.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.007]
[10]何 瑜,唐宽平,马晓颖.5-钙黏蛋白、基质金属蛋白酶9在结直肠癌组织中的表达及临床意义[J].陕西医学杂志,2021,50(5):618.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.026]
HE Yu,TANG Kuanping,MA Xiaoying.Expression and clinical significance of E-cadherin and matrix metalloproteinase 9 in colorectal cancer[J].,2021,50(8):618.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.026]
[11]崔 静,朱俊美,张 燕.血管内皮功能指标与子痫前期严重程度关系及对孕妇流产预测效能研究[J].陕西医学杂志,2023,52(5):608.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.026]
CUI Jing,ZHU Junmei,ZHANG Yan.Relationship between vascular endothelial function indexes and the severity of preeclampsia and its predictive efficacy for abortion[J].,2023,52(8):608.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.026]